Provided by Tiger Trade Technology Pte. Ltd.

Atea Pharmaceuticals, Inc.

5.51
+0.08001.47%
Volume:100.10K
Turnover:545.71K
Market Cap:441.93M
PE:-2.63
High:5.53
Open:5.39
Low:5.25
Close:5.43
52wk High:6.45
52wk Low:2.78
Shares:80.20M
Float Shares:60.05M
Volume Ratio:0.44
T/O Rate:0.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0959
EPS(LYR):-1.9430
ROE:-58.14%
ROA:-36.72%
PB:2.16
PE(LYR):-2.84

Loading ...

Mar 06, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 06, 2025

Major Issues Report

Form 8-K - Current report
Feb 24, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 16, 2024

Correspondence

Form CORRESP - Correspondence
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Jun 21, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
Feb 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]